Human subject protocol (2007-0511) was approved by Institutional Research Board at M.D. Anderson Cancer Center. Tissue microarrays (TMA) were generated using a Beecher instrument with 0.6 mm cores taken from the donor block and placed into the recipient block in triplicate for each case. Tissue microarrays with triplicate cores for each case were generated from primary RCC. Murine tumor TMA were generated with 5 mm cores. TMAs were immunohistochemically stained and analyzed using
inForm software (Caliper Life Sciences). The slides were stained using
Opal 4-color IHC Kit (NEL794001KT) from Perkin Elmer. Microwave treatment (MWT) was applied to perform antigen retrieval, quench endogenous peroxidases, and remove antibodies from earlier staining procedures. Perkin Elmer
AR6 Antigen retrieval buffer (pH 6) was used for CD8 and PD-1 staining while Perkin Elmer
AR9 Antigen Retrieval buffer (pH 9) was used for P-STAT1 staining. The slides were stained with primary antibodies against CD8 and PD-1, corresponding HRP conjugated secondary antibodies, and subsequently TSA dyes to generate Opal signal (CD8, Opal 520; PD-1, Opal 570, or Opal 620). The slides were scanned with the
Vectra image scanning system (Caliper Life Sciences), and signals were unmixed and reconstructed into a composite image with Vectra
inForm software 2.4.6.
Liu X.D., Kong W., Peterson C.B., McGrail D.J., Hoang A., Zhang X., Lam T., Pilie P.G., Zhu H., Beckermann K.E., Haake S.M., Isgandrova S., Martinez-Moczygemba M., Sahni N., Tannir N.M., Lin S.Y., Rathmell W.K, & Jonasch E. (2020). PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nature Communications, 11, 2135.